Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
G-Protein Coupled Receptor 119 (GPR119) activation has demonstrated positive effects on glycemic control, leading to the development of various synthetic G-Protein Coupled Receptor 119 (GPR119) agonists. Numerous clinical trials have been carried out to assess the impact of these agonists on type 2 diabetes. Despite these efforts, most trials have halted at phase II because the GPR119 agonists have only shown modest effects in lowering hyperglycemia.
The most dependable finding about how GPR119 activati…